Literature DB >> 23403415

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.

Sigrun Hope1, Thor Ueland, Nils Eiel Steen, Ingrid Dieset, Steinar Lorentzen, Akiah O Berg, Ingrid Agartz, Pål Aukrust, Ole A Andreassen.   

Abstract

BACKGROUND: Previous studies suggest elevated inflammation in schizophrenia and bipolar disorder, with increased activity of the Interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor (TNF)-alpha, von Willebrand factor (vWf) and osteoprotegerin (OPG). It is unclear how immune activation is involved in the psychopathology. We investigated if elevated inflammation was associated with disease severity (trait) or current symptom level (state), comparing psychotic with general characteristics.
METHODS: Plasma levels of sTNF receptor 1 (sTNF-R1), IL-1 receptor antagonist (IL-1Ra), IL-6, vWf and OPG were measured with ELISA techniques in 322 patients with schizophrenia spectrum and bipolar disorder. Current symptom level (state) was measured with Global Assessment of Functioning (GAF) and Positive and Negative Syndrome Scale (PANSS). Disease severity (trait) was measured with premorbid adjustment scale (PAS), age at onset, number of psychotic episodes and number and length of hospitalizations.
RESULTS: After controlling for confounders, IL-1Ra and TNF-R1 were independently associated with GAF, and significantly correlated with PANSS negative and positive, respectively. In addition, Il-1Ra was associated with PAS, and sTNF-R1 with number of hospitalizations and psychotic episodes. VWf was significantly correlated with psychotic episodes, OPG with hospitalizations and IL-6 with history of psychosis. Linear regression analysis showed that GAF remained associated with sTNF-R1 and IL-1Ra with PANSS, after controlling for the other clinical measures.
CONCLUSIONS: This supports that inflammatory markers, particularly IL-1Ra and sTNF-R1 are associated with both general disease severity and psychotic features. This supports a role of immune activation in the core pathological mechanisms of severe mental disorders.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403415     DOI: 10.1016/j.schres.2012.12.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

2.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

3.  Increased circulating regulatory T cells in medicated people with schizophrenia.

Authors:  Deanna L Kelly; Xin Li; Catherine Kilday; Stephanie Feldman; Sarah Clark; Fang Liu; Robert W Buchanan; Leonardo H Tonelli
Journal:  Psychiatry Res       Date:  2018-09-05       Impact factor: 3.222

4.  Markers of inflammation in schizophrenia: association vs. causation.

Authors:  Peter Manu; Christoph U Correll; Martien Wampers; Alex J Mitchell; Michel Probst; Davy Vancampfort; Marc De Hert
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

5.  Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation.

Authors:  Sarah C Konefal; David Stellwagen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-03-05       Impact factor: 6.237

Review 6.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

7.  Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Schizophr Res       Date:  2015-03-04       Impact factor: 4.939

8.  Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.

Authors:  Marcin Siwek; Magdalena Sowa-Kućma; Krzysztof Styczeń; Paulina Misztak; Rafał J Nowak; Bernadeta Szewczyk; Dominika Dudek; Janusz K Rybakowski; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

Review 9.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

10.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.